Psyence Biomedical (PBM) Interest & Investment Income (2023 - 2025)

Psyence Biomedical's (PBM) quarterly Interest & Investment Income came in at $72815.0 in Q3 2025, up 160.65% quarter-over-quarter from $27936.0 in Q3 2023.

Psyence Biomedical (PBM) Interest & Investment Income (2023 - 2025) Analysis & Trends

Psyence Biomedical's Interest & Investment Income history runs 2 years deep, the most recent figure standing at $72815.0 for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Psyence Biomedical 1.66 Mn 1.66 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 72,815.00
Sep 30, 2023 27,936.00